Citius Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| HEIGHTS CAPITAL MANAGEMENT, INC | 02/17/2026 | 799.93 K | $621.55 K | 100.00% | 3.72% |
| VANGUARD GROUP INC | 01/29/2026 | 199.26 K | $154.82 K | 19.75% | 0.93% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 127.53 K | $99.10 K | 6.48% | 0.59% |
| 02/12/2026 | 59.01 K | $45.85 K | 100.00% | 0.53% | |
| XTX TOPCO LTD | 02/17/2026 | 107.12 K | $83.23 K | 572.77% | 0.50% |
| UBS GROUP AG | 01/29/2026 | 76.44 K | $59.39 K | 194.97% | 0.36% |
| BLACKROCK, INC. | 02/12/2026 | 69.85 K | $54.27 K | 0.00% | 0.33% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 68.10 K | $53.12 K | 198.68% | 0.32% |
| CITADEL ADVISORS LLC | 02/17/2026 | 67.10 K | $52.14 K | -27.30% | 0.31% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 60.84 K | $47.27 K | 179.04% | 0.28% |
| LPL FINANCIAL LLC | 02/11/2026 | 25.07 K | $19.48 K | 100.00% | 0.23% |
| NORTHERN TRUST CORP | 02/17/2026 | 43.97 K | $34.17 K | 62.72% | 0.20% |
| TWO SIGMA SECURITIES, LLC | 02/17/2026 | 28.58 K | $22.21 K | 100.00% | 0.13% |
| STATE STREET CORP | 02/13/2026 | 23.27 K | $18.08 K | 0.00% | 0.11% |
| SCIENTECH RESEARCH LLC | 02/17/2026 | 20.90 K | $16.24 K | 100.00% | 0.10% |
| ARKADIOS WEALTH ADVISORS | 02/13/2026 | 20.00 K | $15.54 K | 0.00% | 0.09% |
| JANE STREET GROUP, LLC | 02/12/2026 | 17.96 K | $13.95 K | -4.91% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 12.90 K | $10.02 K | -73.23% | 0.06% |
| IFP ADVISORS, INC | 02/06/2026 | 7.08 K | $5.50 K | 0.00% | 0.03% |
| CHELSEA COUNSEL CO | 02/24/2026 | 4.63 K | $3.60 K | 0.00% | 0.02% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 4.02 K | $3.12 K | -0.05% | 0.02% |
| CURIO WEALTH, LLC | 02/11/2026 | 2.00 K | $1.60 K | 100.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 2.81 K | $2.18 K | 100.00% | 0.01% |
| MORGAN STANLEY | 02/13/2026 | 2.03 K | $1.58 K | 399.26% | 0.01% |
| QUENT CAPITAL, LLC | 01/29/2026 | 925 | $719 | 756.48% | 0.01% |
| CITIGROUP INC | 02/13/2026 | 843 | $655 | -47.87% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 1.49 K | $1.16 K | 0.00% | 0.01% |
| LUMINIST CAPITAL LLC | 02/13/2026 | 435 | $338 | 0.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 02/18/2026 | 400 | $311 | -98.43% | 0.00% |
| PRINCETON GLOBAL ASSET MANAGEMENT LLC | 01/20/2026 | 160 | $124 | 0.00% | 0.00% |
| MURPHY & MULLICK CAPITAL MANAGEMENT CORP | 02/10/2026 | 160 | $124 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 307 | $238 | -27.25% | 0.00% |
| JPMORGAN CHASE & CO | 02/11/2026 | 120 | $93 | 0.00% | 0.00% |
| SMALLWOOD WEALTH INVESTMENT MANAGEMENT, LLC | 01/23/2026 | 120 | $93 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 107 | $83 | 0.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 02/09/2026 | 50 | $39 | 100.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 02/13/2026 | 84 | $65 | 0.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 02/12/2026 | 80 | $61 | 0.00% | 0.00% |
| FAIRSCALE CAPITAL, LLC | 02/17/2026 | 42 | $33 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 40 | $31 | 0.00% | 0.00% |
| TD WATERHOUSE CANADA INC. | 01/27/2026 | 4 | $3 | 100.00% | 0.00% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 02/05/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 02/11/2026 | 0 | $0 | -100.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 01/23/2026 | 0 | $0 | -100.00% | 0.00% |
| LEGACY WEALTH MANAGMENT, LLC/ID | 02/03/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Citius Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 60 institutional investors and hedge funds held shares of Citius Pharmaceuticals Inc. The most heavily invested institutionals were:
VANGUARD FIDUCIARY TRUST CO: 77,755
UBS Group AG: 55,025
LPL Financial LLC: 25,045
JANE STREET GROUP, LLC: 22,523
Miller Financial Services LLC: 14,000
IFP Advisors, Inc: 7,083
8.00% of Citius Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 3.96 M shares in the last 24 months. This purchase volume represents approximately $3.33 M in transactions.